Recursion Pharmaceuticals

RXRXleader

Recursion uses biological foundation models and robotic cell biology to industrialize drug discovery, generating the world's largest searchable dataset of cellular phenomics.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($75M)

Datos estáticos (cargando finanzas en tiempo real…)

Partnership Revenue (80%)

Other (20%)

Composición de segmentos y clientes principales

Detalles del producto

Recursion OS (Drug Discovery Platform)20%

Biological foundation model trained on 50TB+ of cellular imaging data — screens millions of drug-disease combos at unprecedented speed.

Collaboration Revenue (Roche, Bayer)60%

Target discovery and hit identification partnerships with Roche and Bayer using the OS platform.

Internal Pipeline20%

15+ programs in oncology and neurological rare diseases derived from OS platform.

Relaciones en la Cadena de Suministro

Socios

NVIDIA Corporation

BioNeMo foundation model partnership

Impacto: strategic

roche

$150M target discovery collaboration

Impacto: critical

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de Recursion Pharmaceuticals impulsado por IA.

Información de la Empresa

Sede Central

Salt Lake City, Utah, USA

Fundación

2013

Empleados

1,800

Sitio Web

recursion.com

Estado del sector — 헬스케어

Noticias del sector